Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04982796 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2025 to Dec 31, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Apr 30, 2026 to Dec 31, 2026
    • Site details revised
    v8
  2. Site contact updatedv7
  3. Primary completion date: Dec 31, 2024 to Dec 31, 2025
    • Study completion date: Apr 30, 2025 to Apr 30, 2026
    • Site contact updated
    v6
  4. Re-verified, no change to tracked fieldsv5
  5. Site contact updated
    • Eligibility criteria expanded, about 4 words
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Start date changed from estimate of Jan 15, 2022 to Jul 7, 2022
    • Study sites: 0 to 1
    • Study completion date: Jun 30, 2024 to Apr 30, 2025
  2. Primary endpoints revised (2)
    • Secondary endpoints revised (8)
    • Eligibility criteria expanded, about 3 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.
Trial Details
NCT Number NCT04982796
Lead Sponsor Portland VA Research Foundation, Inc
Collaborators: Steven & Alexandra Cohen Foundation
Conditions
(from sponsor)		 Amphetamine-Related Disorders
Related terms Amphetamine-Related Disorders
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov